Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03897634 · ClinicalTrials.gov registry record · NA
Remote Microphone Candidacy Study
A NA study of Hearing Loss, Sensorineural, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03897634: Completed NA study of Hearing Loss, Sensorineural, sponsored by Northwestern University.
NCT03897634 is a NA study of Hearing Loss, Sensorineural that has completed, run by Northwestern University. The registered enrollment target is 22 participants, below the 785-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03897634, a NA study of Hearing Loss, Sensorineural, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite improvements in digital hearing aid technology, many hearing aid users continue to report difficulty understanding speech in challenging listening environments. Remote microphones have been shown to provide benefit in the most common of these challenging listening environments: distant speakers, background noise, and reverberation. Despite demonstrated benefit, there is a low rate of remote microphone use among adult hearing aid users. One reason for low uptake may be an uncertainty among hearing healthcare providers and potential users regarding expected clinically relevant benefit. This clinical trial will attempt the following: 1. To describe the range of remote microphone benefit among adults with mild-to-moderate sensorineural hearing loss 2. To determine specific individual factors beyond the audiogram that are associated with greater benefit from remote microphones
Primary Outcome
Self assessment, disability based inventory that is used to document outcomes of hearing aid fittings. The APHAB uses a percentile scale (Percent of Problems). This measure has 4 subscales: Ease of communication (EC), Reverberation (RV), Background Noise (BN), and Aversiveness (AV). A lower score indicates a better outcome. We will look at both the global change (defined as EC, RV, and BN scores improving by at least 5 points each) and individual subscales (For EC, RV, or BN a change in 22 point
Conditions Studied
Interventions
- DEVICE Remote Microphone
Study Locations (1)
Illinois
- Northwestern University - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-08-30 |
| Est. Completion | 2020-04-15 |
| Phase | NA |
What the finished NCT03897634 record still lists
NCT03897634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 785-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 1 intervention - of which Remote Microphone is the first listed.
NCT03897634 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03897634 about?
NCT03897634 is a clinical study titled "Remote Microphone Candidacy Study". Despite improvements in digital hearing aid technology, many hearing aid users continue to report difficulty understanding speech in challenging listening environments. Remote microphones have been shown to provide benefit in the most common of these challenging listening environments: distant speak...
What is the current status of trial NCT03897634?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2019-08-30. Estimated completion is 2020-04-15.
What conditions does trial NCT03897634 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural.
What interventions are being tested in trial NCT03897634?
The interventions under investigation include: Remote Microphone (DEVICE).
Who is sponsoring clinical trial NCT03897634?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03897634 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03897634's enrollment target sits among peer trials
22 18th of 20 higher than 3 of 20 other Hearing Loss, Sensorineural trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Barriers and Facilitators to OTC Hearing Aids Success
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Listening Effort in Cochlear Implant Users
RECRUITING · NA
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
-
Reading Outcomes in Children With Vestibular Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI